chronic renal failure. Chronic kidney disease, stage 5
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A history of at least 6 months of hemodialysis The study subjects were being dialyzed with polysulfone capillary dialyzers 3 times a week for 4 h per session The study, the hemodialysis procedure and type of dialyzer were not altered
Exclusion criteria
Exclusion criteria: Inflammatory diseases Infectious diseases Received Aloe vera, omega-3 fatty acid, L-carnitine, vitamin E and/or C supplements Received steroidal and/or non -steroidal anti-inflammatory drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammatory factors. Timepoint: At the begining and the end of week 8. Method of measurement: The serum hs-CRP concentration was determined using enzyme linked immune sorbent assay. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profiles. Timepoint: At the begining and the end of week 8. Method of measurement: The serum lipids was measured auto-analyzer with Pars Azmoon kits.;Dialysis adequacy. Timepoint: At the begining and the end of week 8. Method of measurement: Dialysis adequacy based on Kt/V index was determined for each patient at baseline by a Kt/V calculator software using information recorded in patient files, including pre dialysis blood urea nitrogen (BUN) concentration, post dialysis BUN, the dialysis session length, post dialysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Sabzevar University of Medical Sciences